These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 32324130)
1. Pharmacokinetic linearity of naproxen and efficacy of naproxen sodium at various doses . Lila AM; Parfenov VA; Cattry E; Paredes-Diaz A Int J Clin Pharmacol Ther; 2020 Jun; 58(6):316-331. PubMed ID: 32324130 [TBL] [Abstract][Full Text] [Related]
2. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin. Schiff M; Hochberg MC; Oldenhof J; Brune K Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751 [TBL] [Abstract][Full Text] [Related]
3. Longer analgesic effect with naproxen sodium than ibuprofen in post-surgical dental pain: a randomized, double-blind, placebo-controlled, single-dose trial. Cooper SA; Desjardins P; Brain P; Paredes-Diaz A; Troullos E; Centofanti R; An B Curr Med Res Opin; 2019 Dec; 35(12):2149-2158. PubMed ID: 31402718 [No Abstract] [Full Text] [Related]
4. Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2. Oldenhof J; Hochberg M; Schiff M; Brune K Curr Med Res Opin; 2010 Jun; 26(6):1497-504. PubMed ID: 20429831 [TBL] [Abstract][Full Text] [Related]
5. A look at the safety profile of over-the-counter naproxen sodium: a meta-analysis. Bansal V; Dex T; Proskin H; Garreffa S J Clin Pharmacol; 2001 Feb; 41(2):127-38. PubMed ID: 11210392 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium. Wang-Smith L; Fort J; Zhang Y; Sostek M J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Milsom I; Minic M; Dawood MY; Akin MD; Spann J; Niland NF; Squire RA Clin Ther; 2002 Sep; 24(9):1384-400. PubMed ID: 12380631 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee. Schiff M; Minic M J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960 [TBL] [Abstract][Full Text] [Related]
10. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate. Albrecht C; Melgert BN; Reichen J; Poelstra K; Meijer DK J Drug Target; 1998; 6(2):105-17. PubMed ID: 9886235 [TBL] [Abstract][Full Text] [Related]
11. Dose dependent pharmacokinetics of naproxen in man. Niazi SK; Alam SM; Ahmad SI Biopharm Drug Dispos; 1996 May; 17(4):355-61. PubMed ID: 8743406 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of extended-release versus immediate-release oral naproxen sodium after single and multiple dosing under fed and fasting conditions: two randomized, open-label trials. Laurora I; Wang Y Int J Clin Pharmacol Ther; 2016 Oct; 54(10):750-60. PubMed ID: 27639137 [TBL] [Abstract][Full Text] [Related]
13. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340 [TBL] [Abstract][Full Text] [Related]
14. Why aren't lower, effective, OTC doses available earlier by prescription? Cohen JS Ann Pharmacother; 2003 Jan; 37(1):136-42. PubMed ID: 12503949 [TBL] [Abstract][Full Text] [Related]
15. Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee. Golden HE; Moskowitz RW; Minic M Am J Ther; 2004; 11(2):85-94. PubMed ID: 14999359 [TBL] [Abstract][Full Text] [Related]
16. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis. Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047 [TBL] [Abstract][Full Text] [Related]
17. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study. Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]